Filing Flows

Filing Flows › Comparisons › PRAX vs WHWK

Praxis Precision Medicines vs Whitehawk Therapeutics: PRAX and WHWK compared

Praxis Precision Medicines is the larger company: $7.5M of revenue in its latest quarter (Q4 2024) against $7.1M for Whitehawk Therapeutics (Q1 2025). Praxis Precision Medicines is growing faster (14× against +34% a year earlier). Whitehawk Therapeutics is more profitable, with an operating margin of -213.0% against -857.0%.

Praxis Precision Medicines vs Whitehawk Therapeutics, latest quarterPraxis Precision Medicines vs Whitehawk Therapeutics, latest quarterPraxis Precision Medicines (PRAX)Whitehawk Therapeutics (WHWK)Revenue$7.5M$7.1MRevenue growth, Y/Y14×+34%Operating margin-857.0%-213.0%

Where the money goes: PRAX and WHWK

Praxis Precision Medicines (PRAX) · Q4 2024

Praxis Precision Medicines, Q4 2024: revenue $7.5M (14× year over year), operating margin -857.0%, net loss $58.7M, operating cash flow −$56.1M. The chart follows the revenue to costs, profit and cash.

Whitehawk Therapeutics (WHWK) · Q1 2025

Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.

Praxis Precision Medicines (PRAX)Whitehawk Therapeutics (WHWK)
Latest quarterQ4 2024Q1 2025
Revenue$7.5M$7.1M
Revenue growth, Y/Y14×+34%
Operating margin-857.0%-213.0%
Net earnings−$58.7M$73.0M
Net margin-786.3%—
Operating cash flow−$56.1M−$11.9M
Market value$8.3B—
Analysts’ mean target$650.00—

Questions

Which is bigger, Praxis Precision Medicines or Whitehawk Therapeutics?

Praxis Precision Medicines is the larger company: $7.5M of revenue in its latest quarter (Q4 2024) against $7.1M for Whitehawk Therapeutics (Q1 2025).

Is Praxis Precision Medicines or Whitehawk Therapeutics growing faster?

Praxis Precision Medicines is growing faster (14× against +34% a year earlier).

Which is more profitable, Praxis Precision Medicines or Whitehawk Therapeutics?

Whitehawk Therapeutics is more profitable, with an operating margin of -213.0% against -857.0%.

More: Praxis Precision Medicines earnings · how Praxis Precision Medicines makes money · Whitehawk Therapeutics earnings · how Whitehawk Therapeutics makes money

From the companies' latest 10-Q, 10-K or earnings release (10-K filed Feb 28, 2025; 10-Q filed May 8, 2025). Fiscal quarters can end on different dates. Not investment advice.